Treatment of experienced and na&iuml;ve patients with hepatitis C: focus on telaprevir

Código QR

Treatment of experienced and na&iuml;ve patients with hepatitis C: focus on telaprevir

Roberta D&rsquo;Ambrosio, Alessio Aghemo, Massimo ColomboCentro A.M. e A. Migliavacca, First Division of Gastroenterology, Fondazione IRCCS C&agrave; Granda Ospedale Maggiore Policlinico, Universit&agrave; degli Studi di Milano, Milan, ItalyAbstract: Telaprevir (TVR) is an or...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	D&#39;Ambrosio R, Aghemo A, Colombo M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f7a704012ec34137b54b7b6b2a3986a4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc
por: Eva Poveda, et al.
Publicado: (2010)

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials.
por: Tara L Kieffer, et al.
Publicado: (2012)

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
por: Putcharoen O, et al.
Publicado: (2013)

Cortisol awakening response in drug-naïve panic disorder
por: Jakuszkowiak-Wojten K, et al.
Publicado: (2016)

Magnitude of cytopenias among HIV‑infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART‑experienced children
por: Tsegay YG, et al.
Publicado: (2017)

Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection
por: Chen HW, et al.
Publicado: (2020)

An observational study of bimatoprost 0.01% in treatment-na&iuml;ve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
por: Nixon DR, et al.
Publicado: (2012)

Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in na&iuml;ve myopic choroidal neovascularization
por: Bergamini F, et al.
Publicado: (2012)

Risk factors for the development of depression in patients with hepatitis C taking interferon-&alpha;
por: Smith KJ, et al.
Publicado: (2011)

Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: a meta-analysis.
por: Yuan Kong, et al.
Publicado: (2012)

Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease
por: Zhong M, et al.
Publicado: (2021)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
por: Nanzigu S, et al.
Publicado: (2013)

Persisting primitive reflexes in medication-naïve girls with attention-deficit and hyperactivity disorder
por: Konicarova J, et al.
Publicado: (2013)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine I, et al.
Publicado: (2017)

Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis
por: Sangiorgi D, et al.
Publicado: (2015)

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
por: Degasperi E, et al.
Publicado: (2014)

A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population
por: Yazici Y, et al.
Publicado: (2018)

Bimatoprost/timolol fixed combination versus latanoprost in treatment-naïve glaucoma patients at high risk of progression: a pilot study
por: Gutierrez-Diaz E, et al.
Publicado: (2014)

Relation of Corneal Astigmatism with Various Corneal Image Quality Parameters in a Large Cohort of Naïve Corneas
por: Omar Yousif M, et al.
Publicado: (2020)

Aberrant brain-stem morphometry associated with sleep disturbance in drug-naïve subjects with Alzheimer's disease
por: Lee JH, et al.
Publicado: (2016)

The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
por: Wu X, et al.
Publicado: (2014)

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder
por: Katsuki A, et al.
Publicado: (2019)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Treatment-Naïve Diabetic Macular Edema: A Prospective, Uncontrolled Pilot Study
por: Rush RB, et al.
Publicado: (2021)

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
por: Vadalà M, et al.
Publicado: (2020)

Controlador de élite curado del virus de hepatitis C tras 14 semanas de triple terapia basada en telaprevir
por: Pérez,Diego, et al.
Publicado: (2015)

Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients
por: Cordeiro MF, et al.
Publicado: (2015)

The effectiveness of pictogram intervention in the identification and reporting of adverse drug reactions in naïve HIV patients in Ethiopia: a cross-sectional study
por: Gebreyohannes EA, et al.
Publicado: (2019)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Gro&scaron;ić V, et al.
Publicado: (2014)

Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
por: Pleil AM, et al.
Publicado: (2014)

New developments in the management of hepatitis C virus infection: focus on boceprevir
por: Berenguer M, et al.
Publicado: (2012)

New treatment options in the management of IBD &ndash; focus on colony stimulating factors
por: Josu&eacute; Barahona-Garrido, et al.
Publicado: (2008)

Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
por: D&#39;Arcangelo M, et al.
Publicado: (2013)

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study
por: Okamoto N, et al.
Publicado: (2020)

Altered Function of Superior Parietal Lobule Associated with Perceptive Awareness in First-Episode Drug-Naïve Panic Disorders: A Preliminary fMRI Study
por: Jin H, et al.
Publicado: (2020)

Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimiliars
por: Perrone V, et al.
Publicado: (2016)

Nontyphoidal Salmonella bacteremia in antiretroviral therapy-naïve HIV-infected individuals at three public hospitals in Eastern Ethiopia: prevalence, antimicrobial susceptibility patterns, and associated factors
por: Mitiku H, et al.
Publicado: (2019)

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
por: Chun-Ming Hong, et al.
Publicado: (2021)

Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)
por: Tsuchiya-Kawano Y, et al.
Publicado: (2021)

Review of consensus interferon in the treatment of chronic hepatitis C
por: Th Witth&ouml;ft
Publicado: (2008)

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
por: Hayashi K, et al.
Publicado: (2014)